Shandong Weigao Group Medical Polymer Company Limited (HKG:1066)
Hong Kong · Delayed Price · Currency is HKD 4.580
+0.140 (3.15%)
At close: Mar 27, 2026
HKG:1066 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 13,389 | 13,087 | 13,229 | 13,747 | 13,209 | |
Revenue Growth (YoY) | 2.31% | -1.08% | -3.77% | 4.08% | 13.65% |
Cost of Revenue | 7,057 | 6,551 | 6,619 | 6,454 | 5,873 |
Gross Profit | 6,332 | 6,536 | 6,611 | 7,293 | 7,336 |
Selling, General & Admin | 3,803 | 3,629 | 3,832 | 3,659 | 3,814 |
Research & Development | 646.59 | 625.23 | 592.85 | 556.44 | 503.08 |
Operating Expenses | 4,484 | 4,262 | 4,430 | 4,251 | 4,333 |
Operating Income | 1,847 | 2,274 | 2,181 | 3,043 | 3,003 |
Interest Expense | -255.85 | -249.57 | -272.97 | -191.4 | -140.44 |
Interest & Investment Income | 190.86 | 232.6 | 238.57 | 187.31 | 156.23 |
Earnings From Equity Investments | 100.85 | 74.77 | 76.86 | 75.11 | 69.46 |
Currency Exchange Gain (Loss) | -121.78 | 56.44 | -16.6 | 138.33 | -68.1 |
Other Non Operating Income (Expenses) | 50.93 | 158.53 | 144.89 | 158.23 | 90.63 |
EBT Excluding Unusual Items | 1,812 | 2,547 | 2,352 | 3,410 | 3,111 |
Gain (Loss) on Sale of Investments | 76.65 | - | - | 137.16 | - |
Gain (Loss) on Sale of Assets | 73.27 | 2.91 | -1.55 | 108.75 | -2.93 |
Asset Writedown | -10.98 | -0.17 | -9.7 | -10.81 | - |
Legal Settlements | 80.09 | 4.47 | 28.55 | -259.61 | -229.85 |
Pretax Income | 2,031 | 2,554 | 2,369 | 3,386 | 2,878 |
Income Tax Expense | 320.79 | 391.03 | 307.59 | 435.59 | 420.07 |
Earnings From Continuing Operations | 1,711 | 2,163 | 2,062 | 2,950 | 2,458 |
Net Income to Company | 1,711 | 2,163 | 2,062 | 2,950 | 2,458 |
Minority Interest in Earnings | -98.49 | -96.05 | -59.7 | -186.06 | -181.85 |
Net Income | 1,612 | 2,067 | 2,002 | 2,764 | 2,276 |
Net Income to Common | 1,612 | 2,067 | 2,002 | 2,764 | 2,276 |
Net Income Growth | -21.99% | 3.23% | -27.57% | 21.45% | 9.06% |
Shares Outstanding (Basic) | 4,535 | 4,539 | 4,529 | 4,506 | 4,501 |
Shares Outstanding (Diluted) | 4,538 | 4,549 | 4,540 | 4,527 | 4,516 |
Shares Change (YoY) | -0.22% | 0.19% | 0.30% | 0.23% | 0.52% |
EPS (Basic) | 0.36 | 0.46 | 0.44 | 0.61 | 0.51 |
EPS (Diluted) | 0.35 | 0.45 | 0.44 | 0.61 | 0.50 |
EPS Growth | -21.14% | 2.27% | -27.92% | 21.18% | 9.51% |
Free Cash Flow | - | 2,192 | 2,151 | 1,225 | 1,967 |
Free Cash Flow Per Share | - | 0.48 | 0.47 | 0.27 | 0.43 |
Dividend Per Share | 0.157 | 0.215 | 0.168 | 0.165 | 0.142 |
Dividend Growth | -27.16% | 28.44% | 1.64% | 16.20% | 9.23% |
Gross Margin | 47.29% | 49.94% | 49.97% | 53.05% | 55.54% |
Operating Margin | 13.80% | 17.37% | 16.49% | 22.13% | 22.73% |
Profit Margin | 12.04% | 15.79% | 15.13% | 20.11% | 17.23% |
Free Cash Flow Margin | - | 16.75% | 16.26% | 8.91% | 14.89% |
EBITDA | 2,769 | 3,195 | 3,051 | 3,809 | 3,708 |
EBITDA Margin | 20.68% | 24.42% | 23.06% | 27.70% | 28.07% |
D&A For EBITDA | 921.68 | 921.68 | 869.38 | 765.98 | 705.58 |
EBIT | 1,847 | 2,274 | 2,181 | 3,043 | 3,003 |
EBIT Margin | 13.80% | 17.37% | 16.49% | 22.13% | 22.73% |
Effective Tax Rate | 15.79% | 15.31% | 12.98% | 12.86% | 14.60% |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.